# LASMIDITAN
> **ANDA219669** · Abbreviated New Drug Application (Generic) · Sponsor: HUMANWELL PHARMACEUTICAL US INC · Approved 2025-12-19
## Drug
- **FDA Application Number:** ANDA219669
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LASMIDITAN
- **Generic name:** Lasmiditan
- **Active ingredients:** LASMIDITAN
- **Dosage form:** TABLET
- **Route:** —
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** HUMANWELL PHARMACEUTICAL US INC
- **First approval:** 2025-12-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219669)
---
*MORVS · CC0 1.0*